(CHRW) CH Robinson Worldwide - Overview
Stock: Truckload, LTL, Intermodal, Freight-Forwarding, Produce, Customs
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.15% |
| Yield on Cost 5y | 3.12% |
| Yield CAGR 5y | 4.60% |
| Payout Consistency | 100.0% |
| Payout Ratio | 49.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 27.6% |
| Relative Tail Risk | -16.9% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.11 |
| Alpha | 98.79 |
| Character TTM | |
|---|---|
| Beta | 0.684 |
| Beta Downside | 0.829 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.50% |
| CAGR/Max DD | 0.84 |
Description: CHRW CH Robinson Worldwide January 02, 2026
C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) is a non-asset-based logistics provider that connects shippers with carriers across North America and globally. It operates two main segments-North American Surface Transportation and Global Forwarding-offering truckload, LTL, intermodal, air freight, customs brokerage, managed-warehouse, and door-to-door services. Through its Robinson Fresh subsidiary, the firm also markets perishable produce to grocery retailers, restaurants, and food-service distributors.
In FY 2023 the company generated roughly $16.5 billion in revenue, with an adjusted EBITDA margin near 11 %, reflecting the scalability of its technology-driven brokerage model. Its Transportation Management System (TMS) processes over 1 billion shipments annually, and the fresh-produce business contributes about 5 % of total revenue while delivering higher gross margins due to value-added handling.
Key economic drivers for CHRW include sustained e-commerce growth, which fuels demand for fast, reliable last-mile and intermodal solutions, and ongoing freight-capacity constraints that elevate brokerage spreads. Macro-level factors such as diesel price volatility, driver labor shortages, and fluctuating interest rates also influence pricing power and volume trends across the logistics sector.
For a deeper quantitative view of CHRW’s valuation metrics, you might explore the analysis on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 587.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.18 > 0.02 and ΔFCF/TA 9.01 > 1.0 |
| NWC/Revenue: 5.96% < 20% (prev 3.64%; Δ 2.32% < -1%) |
| CFO/TA 0.18 > 3% & CFO 914.5m > Net Income 587.1m |
| Net Debt (1.47b) to EBITDA (975.6m): 1.51 < 3 |
| Current Ratio: 1.53 > 1.5 & < 3 |
| Outstanding Shares: last quarter (121.7m) vs 12m ago -0.52% < -2% |
| Gross Margin: 8.37% > 18% (prev 0.07%; Δ 830.0% > 0.5%) |
| Asset Turnover: 313.5% > 50% (prev 334.6%; Δ -21.08% > 0%) |
| Interest Coverage Ratio: 6.02 > 6 (EBITDA TTM 975.6m / Interest Expense TTM 145.1m) |
Altman Z'' 6.86
| A: 0.19 (Total Current Assets 2.80b - Total Current Liabilities 1.83b) / Total Assets 5.06b |
| B: 1.19 (Retained Earnings 6.01b / Total Assets 5.06b) |
| C: 0.17 (EBIT TTM 872.8m / Avg Total Assets 5.18b) |
| D: 0.57 (Book Value of Equity 1.85b / Total Liabilities 3.21b) |
| Altman-Z'' Score: 6.86 = AAA |
Beneish M -3.18
| DSRI: 1.06 (Receivables 2.52b/2.58b, Revenue 16.23b/17.72b) |
| GMI: 0.88 (GM 8.37% / 7.38%) |
| AQI: 1.05 (AQ_t 0.37 / AQ_t-1 0.35) |
| SGI: 0.92 (Revenue 16.23b / 17.72b) |
| TATA: -0.06 (NI 587.1m - CFO 914.5m) / TA 5.06b) |
| Beneish M-Score: -3.18 (Cap -4..+1) = AA |
What is the price of CHRW shares?
Over the past week, the price has changed by +2.89%, over one month by +19.64%, over three months by +35.87% and over the past year by +112.12%.
Is CHRW a buy, sell or hold?
- StrongBuy: 11
- Buy: 2
- Hold: 11
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the CHRW price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 193.4 | -3.6% |
| Analysts Target Price | 193.4 | -3.6% |
| ValueRay Target Price | 241.9 | 20.6% |
CHRW Fundamental Data Overview February 07, 2026
P/E Forward = 33.1126
P/S = 1.4598
P/B = 12.6391
P/EG = 2.3312
Revenue TTM = 16.23b USD
EBIT TTM = 872.8m USD
EBITDA TTM = 975.6m USD
Long Term Debt = 1.18b USD (from longTermDebt, two quarters ago)
Short Term Debt = 72.2m USD (from shortTermDebt, last quarter)
Debt = 1.63b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.47b USD (from netDebt column, last quarter)
Enterprise Value = 25.17b USD (23.70b + Debt 1.63b - CCE 160.9m)
Interest Coverage Ratio = 6.02 (Ebit TTM 872.8m / Interest Expense TTM 145.1m)
EV/FCF = 28.12x (Enterprise Value 25.17b / FCF TTM 894.9m)
FCF Yield = 3.56% (FCF TTM 894.9m / Enterprise Value 25.17b)
FCF Margin = 5.51% (FCF TTM 894.9m / Revenue TTM 16.23b)
Net Margin = 3.62% (Net Income TTM 587.1m / Revenue TTM 16.23b)
Gross Margin = 8.37% ((Revenue TTM 16.23b - Cost of Revenue TTM 14.87b) / Revenue TTM)
Gross Margin QoQ = 8.18% (prev 8.62%)
Tobins Q-Ratio = 4.97 (Enterprise Value 25.17b / Total Assets 5.06b)
Interest Expense / Debt = 0.84% (Interest Expense 13.7m / Debt 1.63b)
Taxrate = 18.14% (30.2m / 166.5m)
NOPAT = 714.5m (EBIT 872.8m * (1 - 18.14%))
Current Ratio = 1.53 (Total Current Assets 2.80b / Total Current Liabilities 1.83b)
Debt / Equity = 0.88 (Debt 1.63b / totalStockholderEquity, last quarter 1.85b)
Debt / EBITDA = 1.51 (Net Debt 1.47b / EBITDA 975.6m)
Debt / FCF = 1.64 (Net Debt 1.47b / FCF TTM 894.9m)
Total Stockholder Equity = 1.81b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.34% (Net Income 587.1m / Total Assets 5.06b)
RoE = 32.52% (Net Income TTM 587.1m / Total Stockholder Equity 1.81b)
RoCE = 29.20% (EBIT 872.8m / Capital Employed (Equity 1.81b + L.T.Debt 1.18b))
RoIC = 23.04% (NOPAT 714.5m / Invested Capital 3.10b)
WACC = 7.93% (E(23.70b)/V(25.33b) * Re(8.43%) + D(1.63b)/V(25.33b) * Rd(0.84%) * (1-Tc(0.18)))
Discount Rate = 8.43% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.85%
[DCF Debug] Terminal Value 81.48% ; FCFF base≈720.9m ; Y1≈889.2m ; Y5≈1.51b
Fair Price DCF = 207.2 (EV 25.95b - Net Debt 1.47b = Equity 24.48b / Shares 118.1m; r=7.93% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -25.82 | EPS CAGR: -12.73% | SUE: 0.60 | # QB: 0
Revenue Correlation: -84.07 | Revenue CAGR: -13.76% | SUE: -0.40 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.26 | Chg30d=-0.052 | Revisions Net=-3 | Analysts=24
EPS current Year (2026-12-31): EPS=6.05 | Chg30d=+0.053 | Revisions Net=+3 | Growth EPS=+18.8% | Growth Revenue=+2.2%
EPS next Year (2027-12-31): EPS=7.15 | Chg30d=+0.329 | Revisions Net=+10 | Growth EPS=+18.3% | Growth Revenue=+6.6%